Adenovirus Vaccines
Live oral vaccine for adenovirus types 4 and 7 (military use)
This page catalogs 1 adenovirus vaccine product. The Adenovirus Type 4 and 7 vaccine is unique among US-licensed vaccines in being restricted to military use, addressing acute respiratory disease outbreaks that historically affected military training facilities. Production was interrupted from 1999 to 2011, during which adenovirus outbreaks resumed among recruits.
Last updated: April 2026.
Adenovirus Vaccine Catalog
| Trade Name | Generic Designation | Manufacturer | Vaccine Type | Regulatory Status & Year | Key Notes |
|---|---|---|---|---|---|
| Adenovirus Type 4 and 7 Vaccine | Adenovirus Type 4 and Type 7 vaccine, live oral | Teva (Barr) | Live oral | FDA Licensed, 2011 | Military use only |
Sources
Regulatory data sourced from FDA CBER Vaccines Licensed for Use in the United States (March 2026). Catalog scope informed by Khan, Shaz, The Ultimate Vaccine Timeline.